These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1404215)

  • 1. Measurement of HDL cholesterol.
    Grubits J
    J R Soc Med; 1992 Aug; 85(8):509. PubMed ID: 1404215
    [No Abstract]   [Full Text] [Related]  

  • 2. Response.
    Bosomworth J
    Can Fam Physician; 2014 Jan; 60(1):40. PubMed ID: 24600752
    [No Abstract]   [Full Text] [Related]  

  • 3. Lower treatment thresholds.
    Torontour S
    Can Fam Physician; 2014 Jan; 60(1):39-40. PubMed ID: 24452557
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gemfibrozil in the differential therapy of disorders of fat metabolism].
    Ebner F
    Fortschr Med; 1992 Oct; 110(28):523-6. PubMed ID: 1398412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Net mass transfer of cholesteryl esters from low density lipoproteins to high density lipoproteins in plasma from normolipidemic subjects.
    Van Tol A; Scheek LM; Groener JE
    Arterioscler Thromb; 1991; 11(1):55-63. PubMed ID: 1988004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol and prostate cancer.
    Harv Mens Health Watch; 2011 Jun; 15(11):6-7. PubMed ID: 21706781
    [No Abstract]   [Full Text] [Related]  

  • 7. LDL-cholesterol and HDL-cholesterol concentrations decrease during the day.
    Miida T; Nakamura Y; Mezaki T; Hanyu O; Maruyama S; Horikawa Y; Izawa S; Yamada Y; Matsui H; Okada M
    Ann Clin Biochem; 2002 May; 39(Pt 3):241-9. PubMed ID: 12038599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
    Guérin M; Le Goff W; Lassel TS; Van Tol A; Steiner G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):282-8. PubMed ID: 11156866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mathematical assessment of the degree of changes in the level of lipids and intensity of lipid peroxidation in cerebrovascular diseases].
    Redrova OIu
    Klin Lab Diagn; 1995; (5):39-41. PubMed ID: 7582775
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular mechanisms of lipid disorders in nephrotic syndrome.
    Vaziri ND
    Kidney Int; 2003 May; 63(5):1964-76. PubMed ID: 12675893
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro.
    Nishimoto T; Amano Y; Tozawa R; Ishikawa E; Imura Y; Yukimasa H; Sugiyama Y
    Br J Pharmacol; 2003 Jul; 139(5):911-8. PubMed ID: 12839864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglyceride-rich lipoprotein remnant levels and metabolism: time to adopt these orphan risk factors?
    Brinton EA; Nanjee MN; Hopkins PN
    J Am Coll Cardiol; 2004 Jun; 43(12):2233-5. PubMed ID: 15193685
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between high-density lipoprotein-cholesterol and malondialdehyde-modified low-density lipoprotein concentrations.
    Kondo A; Li J; Manabe M; Saito K; Kanno T; Maekawa M
    J Atheroscler Thromb; 2003; 10(2):72-8. PubMed ID: 12740480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetes mellitus and secondary hyperlipidemia].
    Takeuchi I
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1778-83. PubMed ID: 1479218
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dyslipoproteinemia as a coronary risk factor].
    Yamamura T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():738-45. PubMed ID: 12735059
    [No Abstract]   [Full Text] [Related]  

  • 16. Which patients need aggressive lipid-altering therapy?
    Hunninghake DB
    Cleve Clin J Med; 1993; 60(6):483-4. PubMed ID: 8287511
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metabolism of magnesium and lipid disturbances in chronic renal failure].
    Fijałkowska-Morawska J; Chrzanowski W
    Pol Arch Med Wewn; 1997 Oct; 98(10):327-31. PubMed ID: 9557087
    [No Abstract]   [Full Text] [Related]  

  • 18. Beyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis prevention.
    Parhofer KG
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):414-7. PubMed ID: 16151973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endurance training has little effect on active muscle free fatty acid, lipoprotein cholesterol, or triglyceride net balances.
    Jacobs KA; Krauss RM; Fattor JA; Horning MA; Friedlander AL; Bauer TA; Hagobian TA; Wolfel EE; Brooks GA
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E656-65. PubMed ID: 16684856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ApoE4 allele on total cholesterol levels of children in northern Spain.
    Bercedo-Sanz A; González-Lamuño D; Málaga S; García-Fuentes M
    Clin Genet; 1999 Jan; 55(1):69-70. PubMed ID: 10066038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.